-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CnaCwEcrsyTekFvesGePH1INvP7nXGJYUyZX2WjPGcdwR3MCqMrEgHuEDTlRttA8 ZWmt8hop8FcGoe3xuzJFlg== 0000727008-04-000085.txt : 20041103 0000727008-04-000085.hdr.sgml : 20041103 20041103103529 ACCESSION NUMBER: 0000727008-04-000085 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041101 FILED AS OF DATE: 20041103 DATE AS OF CHANGE: 20041103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EZ EM INC CENTRAL INDEX KEY: 0000727008 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 111999504 STATE OF INCORPORATION: DE FISCAL YEAR END: 0529 BUSINESS ADDRESS: STREET 1: 717 MAIN ST CITY: WESTBURY STATE: NY ZIP: 11590 BUSINESS PHONE: 5163338230 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ECHENBERG PAUL S CENTRAL INDEX KEY: 0001235631 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 333-100878 FILM NUMBER: 041115090 BUSINESS ADDRESS: STREET 1: C/O SCHRODERS & ASSOCIATES CANADA STREET 2: 1800 MCGILL COLLEGE AVE. #3000 CITY: MONTREAL QUEBEC CANADA STATE: A8 ZIP: H3A 3J6 BUSINESS PHONE: 5144800120 MAIL ADDRESS: STREET 1: 623 SYDENHAM AVE CITY: WESTMONT QUEBEC CANADA STATE: A8 ZIP: H3Y 2Z3 4 1 ech110.xml X0202 4 2004-11-01 0 0000727008 EZ EM INC EZM 0001235631 ECHENBERG PAUL S 717 MAIN STREET WESTBURY NY 115905021 1 0 0 0 Common Stock 2004-11-01 4 A 0 1000 0 A 38339 D Common Stock Option 2.3681 1996-05-15 2005-05-14 Common Stock 29919 29919 D Common Stock Option 2.5161 1996-06-03 2005-06-02 Common Stock 995 995 D Common Stock Option 8.0794 1997-06-01 2006-05-31 Common Stock 967 967 D Common Stock Option 4.7890 1998-05-31 2007-05-30 Common Stock 940 940 D Common Stock Option 3.8006 1999-05-30 2008-05-29 Common Stock 912 912 D Common Stock Option 3.2346 2000-05-29 2009-05-28 Common Stock 912 912 D Common Stock Option 4.2049 2001-06-03 2010-06-02 Common Stock 912 912 D Common Stock Option 3.3639 2002-06-02 2011-06-01 Common Stock 912 912 D Common Stock Option 5.8222 2003-06-01 2012-05-31 Common Stock 912 912 D Common Stock Option 5.4340 2004-05-31 2013-05-30 Common Stock 912 912 D Common Stock Option 12.0971 2005-05-29 2014-05-28 Common Stock 912 912 D Director compensation in the form of a Restricted Stock Grant. Options granted under E-Z-EM's Directors and Consultants Stock Option Plan. This option was previously reported as covering 32,781 shares at an exercise price of $3.6606 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $2.3681 per share and the number of shares was reduced to 29,919, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off. This option was previously reported as covering 1,091 shares at an exercise price of $3.8894 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $2.5161 per share and the number of shares was reduced to 995, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off. This option was previously reported as covering 1,060 shares at an exercise price of $12.4894 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $8.0794 per share and the number of shares was reduced to 967, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off. This option was previously reported as covering 1,030 shares at an exercise price of $7.4029 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $4.7890 per share and the number of shares was reduced to 940, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off. This option was previously reported as covering 1,000 shares at an exercise price of $5.875 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $3.8006 per share and the number of shares was reduced to 912, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off. This option was previously reported as covering 1,000 shares at an exercise price of $5.00 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $3.2346 per share and the number of shares was reduced to 912, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off. This option was previously reported as covering 1,000 shares at an exercise price of $6.50 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $4.2049 per share and the number of shares was reduced to 912, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off. This option was previously reported as covering 1,000 shares at an exercise price of $5.20 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $3.3639 per share and the number of shares was reduced to 912, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off. This option was previously reported as covering 1,000 shares at an exercise price of $9.00 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $5.8222 per share and the number of shares was reduced to 912, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off. This option was previously reported as covering 1,000 shares at an exercise price of $8.40 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $5.4340 per share and the number of shares was reduced to 912, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off. This option was previously reported as covering 1,000 shares at an exercise price of $18.70 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $12.0971 per share and the number of shares was reduced to 912, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off. By: Joseph A. Cacchioli, as Attorney-In-Fact 2004-11-03 -----END PRIVACY-ENHANCED MESSAGE-----